Scientists discover rare genetic condition that attacks kids’ immune systems
What Is Cyclic Vomiting Syndrome And How Is It Diagnosed?
When someone suddenly develops a bout of intense nausea, vomiting, stomach pain and continuous retching that lasts a day or two or sometimes more, they might suspect food poisoning or a gastrointestinal virus is to blame. But if this happens multiple times per year, it could be a sign of cyclic vomiting syndrome, an under-recognized disorder that's believed to affect approximately 2 percent of people in the United States.
In July, partly because the disorder remains underdiagnosed and under-treated, the American Gastroenterological Association issued new clinical guidance to help doctors and patients recognize the signs and symptoms of cyclic vomiting syndrome (CVS, for short). In a nutshell, CVS is a chronic disorder related to gut-brain interaction, and it's characterized by recurrent episodes of nausea, vomiting, and dry heaving, separated by symptom-free periods in between. The episodes themselves tend to be downright debilitating, leading to pain, misery, and often dehydration, as well as lost work and school days because people can't stray far from the bathroom.
"There is increasing recognition that this disorder is more prevalent than we once thought," says David Levinthal, a gastroenterologist and neuroscientist and director of the Neurogastroenterology and Motility Center at the University of Pittsburgh Medical Center. "This is not a condition a lot of GI doctors think about. There are many patients out there who are suffering and not getting diagnosed and treated."
This may be partly because like other disorders of the gut-brain interaction, it's a condition that's not prioritized in medical education, says Christopher Vélez, a gastroenterologist and associate program director of the advanced fellowship in gastrointestinal motility and functional disease at the Massachusetts General Hospital Center for Neurointestinal Health in Boston.
"It's sort of like a gut migraine—an abnormal, uncontrolled, neurologically mediated series of events," Vélez says. But because modern diagnostics can't show doctors what's wrong, "sometimes it's seen as made up. And sometimes patients are blamed for their symptoms, even as their quality of life is significantly impaired."
Who's susceptible and whyWhile CVS can afflict anyone, it's more common among children, women, and young adults.
"A large percentage of kids who have it outgrow it," says Anthony Lembo, a gastroenterologist and director of research at the Digestive Disease Institute at the Cleveland Clinic. "For adults, it's not as clear."
Summer Flash Sale – Up to $20 off!
Among adults, anxiety, depression, and/or panic disorder often coexist with CVS, as do migraines. And, like migraines, CVS sometimes runs in families, Lembo says. In addition, the disorder is slightly more common among people with seizure disorders.
(A partial solution for migraines and PTSD? This approach offers hope.)
Among those who have CVS, "everyone has a different trigger," says Levinthal, and sometimes triggers are hard to identify. Stress is a common trigger, and so are sleep loss, hormonal fluctuations related to the menstrual cycle, travel, motion sickness, periods of intense exercise, and physiological sources of stress such as an illness or surgery.
"If you always had a sensitive GI system, it's a set-up for this," says Vélez. "It makes one more susceptible to psychosocial triggers."
Marissa Cohen started having consistent flare-ups of CVS when she was two years old. Sometimes the vomiting would be so profuse that she'd have nothing left in her stomach and bile would come up. Despite going through years of tests, Cohen didn't receive a diagnosis of CVS until she was eight years old.
"That was frustrating for my parents and me because we knew something was wrong but there wasn't much we could do about it without an official diagnosis," Cohen recalls.
Often, she'd end up in a hospital emergency room where she'd receive intravenous fluids and medications to stop the vomiting. The drugs would usually put her to sleep and she'd "wake up feeling like nothing happened—it's such a crazy on-and-off switch," says Cohen, now a 21-year-old college student in Pennsylvania.
Most people with CVS typically have two to four episodes per year. "This disorder is not a monolith," Levinthal says. "There's a wide range of severity."
If someone has fewer than four episodes per year with each one lasting less than two days, they are considered to have mild CVS, according to the AGA. If someone has four or more episodes per year, with each lasting more than two days and they require a hospital emergency department visit or hospitalization, they're diagnosed as having moderate-to-severe CVS.
You May Also Like
SCIENCE
Many people wean off antidepressants too quickly. That can be dangerous.SCIENCE
What are the signs of dementia—and why is it so hard to diagnose?SCIENCE
How magnesium affects your sleep and anxiety Diagnosis and treatmentTo rule out conditions (such as an obstruction) that could produce similar symptoms, an endoscopy and/or imaging tests (such as a CT scan or ultrasound) of the upper gastrointestinal tract are sometimes ordered.
Bloodwork—including a complete blood count, and tests to measure blood levels of electrolytes and glucose and liver enzymes—and urinalysis are also part of the diagnostic picture. But the mainstay of the diagnosis is taking a thorough medical history.
(What's the source of your headaches? It could be your neck.)
"It is the recognition of a pattern that is the critical step," Levinthal says. While CVS flare-ups can happen at any time of day, most occur in the early morning.
Those who are diagnosed with moderate-to-severe CVS often take preventive medications—such as tricyclic antidepressants (like amitriptyline or nortriptyline) or anti-seizure drugs (like topiramate, zonamisamide, or levetiracetem)—on a daily basis. These don't eliminate flare-ups; the goal is to extend the length of time between them and/or to reduce the length and severity of the episodes.
"One of the nice things about CVS is treating it is a choose-your-own-adventure situation," says Vélez, referring to the fact that different treatments can be tried or combined in a particular person.
Many people with the disorder experience prodromal symptoms—such as abdominal pain, headache, mental fog, shakiness, or anxiety—an hour or so before they start vomiting.
"About 70 percent of patients can identify when an attack is coming on," Levinthal says. "If you can take medicine as soon as you recognize it's going to happen, that's when you have the best chance to turn it off."
For those with mild CVS and the moderate-to-severe form, abortive therapies such as triptan drugs (which are used for migraines), antiemetics (a.K.A., anti-nausea drugs such as ondansetron, promethazine, or prochlorperazine), or sedatives (such as alprazolam or diphenhydramine) are prescribed to try to stop an episode in its tracks.
Because it may be hard for people to keep an oral medicine down during an episode, many of these drugs can be taken through other delivery methods: sublingual (under the tongue), a nasal spray, or a rectal suppository.
Many people, like Cohen, rely on two or more drugs to treat CVS. These days, she takes a tricyclic antidepressant each day to try to prevent attacks and she's armed with rescue medications if she wakes up feeling nauseous, for example. While she ends up in the ER less often than she used to, she still typically has one to five CVS flare-ups per year and must be careful about where she travels, in case she needs medical attention.
"The hardest part about it," she says, "is I really don't know what's going to trigger an episode."
(Botox to treat depression and anxiety? Experts have found a link.)
If people can't get a grip on their symptoms or they become dehydrated at home, a visit to a hospital ED for intravenous fluids and IV abortive therapy is in order.
Some people with CVS use cannabis, either recreationally or to ease their symptoms. The trouble is, sometimes it's difficult to distinguish a condition called cannabinoid hyperemesis syndrome (CHS) from CVS. With CHS, chronic use of cannabis—defined as more than four times per week for more than a year—can be associated with recurrent nausea, vomiting, and abdominal pain.
That's why some gastroenterologists recommend cannabis-users with CVS abstain for three to six months to see if it makes a difference, Vélez says. If they continue to experience nausea-and-vomiting episodes after that, CHS can be ruled out.
To get some relief from the symptoms, people with CVS often take hot baths or showers, sometimes multiple times per day. People with CVS are advised to get regular sleep, avoid prolonged fasting, and engage in stress-management practices such as meditation, which has been shown to be helpful.
"There are a lot of people with this condition and it is treatable," Levinthal says. "I want patients to advocate for themselves because help is out there."
Addressing Medical Trauma In The Hemophilia Community
Priscilla Oren, a member of the hemophilia community, recently shared her family's history with me. Her son was a victim of the "hemophilia holocaust" in the 1980s. During that time, many people with hemophilia contracted HIV/AIDS and hepatitis from the factor products used to treat their bleeding disorders.
As a result, Oren's daughter has become skeptical and avoidant of the medical community. She chose not to have children due to her brother's experiences. Recently, she was diagnosed with stage 4 breast cancer. Her refusal to accept traditional medical treatment has made her situation precarious.
"People do not realize how far-reaching and horrific the effects of the hemophilia holocaust have been on our families," Oren told me.
Medical trauma refers to the psychological and emotional distress people may experience as a result of medical procedures, treatments, or interactions with healthcare professionals. Symptoms of medical trauma can include anxiety, depression, post-traumatic stress disorder, avoidance of medical care, and distrust of healthcare providers.
Medical trauma is very real. I lived through the hemophilia holocaust and emerged forever skeptical of doctors and the medical community. It is why I refuse to use factor replacement products to treat my bleeding disorders unless my situation is severe. When I was offered prophylactic treatment to keep my factor levels up, I chose instead to treat on demand.
AnxietyWhen discussing my decision to avoid prophylactic treatment with my hematologist, I often refer to the period of my life when my treatment could have killed me. My liver has issues, which I believe to be a result of the treatment I received in the '80s. When I do have to infuse my medication, the decision is wrought with severe anxiety. I keep anxiety medication on hand for these occasions.
Kayla Mack has type 3 von Willebrand disease, a severe form of the bleeding disorder. We both received cryoprecipitate as a treatment during the "tainted blood era." When I interviewed her in 2022, it was clear that she also suffered from medical trauma.
"I have a lot of medical trauma associated with my childhood. It is causing me issues as an adult with [an] enormous trauma response to each step of getting better care for myself," she said.
Mack and I, along with countless other women with bleeding disorders, suffer from medical trauma associated with emergency rooms. Imagine trying to explain to an ER doctor that you have a bleeding disorder when they don't believe that women with bleeding disorders exist.
"I have a lot of medical trauma associated with ER doctors, as I've been pretty consistently gaslighted and treated like a hysterical-looking woman with a pretty minor bleed, yet here I am in the ER. They never pay attention to me. I have zero confidence in emergency room[s] handling a bleed correctly," Mack said.
These stories underscore the importance of recognizing and addressing medical trauma within the hemophilia community. If you are experiencing medical trauma, please consider reaching out to the social worker at your hemophilia treatment center for support and guidance.
Note: Hemophilia News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. The opinions expressed in this column are not those of Hemophilia News Today or its parent company, Bionews, and are intended to spark discussion about issues pertaining to hemophilia.
Crohn's Disease News
Nov. 7, 2023 — Researchers have shown that changes can be detected in blood tests up to eight years before a diagnosis of Crohn's disease and up to three years before a diagnosis of ulcerative ...
Nov. 1, 2023 — Inflammatory bowel disease (IBD) is an independent risk factor for serious infection, even at very low levels of gastrointestinal ...
Oct. 26, 2023 — Inflammatory bowel diseases (IBDs), such as Crohn's disease or ulcerative colitis, arise when there is a dysregulation of cell signalling pathways, leading to a chronic inflammatory response. ...
Oct. 26, 2023 — According to a new study, 2 fungi used to produce food products have potential probiotic effects on gut ...
Sep. 19, 2023 — Adults with atopic dermatitis (AD) have a 34 percent increased risk of developing new-onset inflammatory bowel disease (IBD) compared with individuals who do not have the skin condition, and children ...
Sep. 7, 2023 — Millions of Americans have inflammatory bowel disease (IBD), which occurs in one of two forms: Crohn's disease or ulcerative colitis. Though the two have similar symptoms, they require different ...
July 28, 2023 — Research found that direct injection of neonatal mesenchymal stem cells, derived from heart tissue discarded during surgery, reduces intestinal inflammation and promotes wound healing in a mouse ...
July 17, 2023 — Chronic inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, is on the rise worldwide. The benefits of current medications are limited by problematic side effects. A ...
July 5, 2023 — A study of the genetic variation that makes mice more susceptible to bowel inflammation after a high-fat diet has identified candidate genes which may drive inflammatory bowel disease (IBD) in ...
July 3, 2023 — A new study shows the sugar sialic acid, which makes up part of the protective intestinal mucus layer, fuels disease-causing bacteria in the gut. The findings suggest a potential treatment target for ...
June 21, 2023 — Probiotics can help maintain a healthy gut microbiome or restore populations of 'good bacteria' after a heavy course of antibiotics. But now, they could also be used as an effective ...
June 8, 2023 — For the first time, cells involved with the communication between stress responses in the brain and inflammation in the gastrointestinal (GI) tract have been identified in animal models. Glial cells, ...
Apr. 20, 2023 — Investigators have identified a genetic variant that increases people's risk of developing perianal Crohn's disease, the most debilitating manifestation of Crohn's disease. The variant ...
Apr. 7, 2023 — A new study could help improve personalized medicine approaches in inflammatory bowel disease by understanding how patients with variants in the PTPN2 gene develop ...
Apr. 4, 2023 — Fresh insights into how our bodies interact with the microbes living in our guts suggest that a two-drug combination may offer a new way to treat inflammatory bowel diseases such as Crohn's ...
Mar. 31, 2023 — Researchers have succeeded in developing an E. Coli-based 'smart microbe' that secretes therapeutic payloads, including antibodies, into the gut. The genetically modified beneficial strain ...
Feb. 28, 2023 — Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently available drugs have little ...
Feb. 23, 2023 — Psyllium fiber protects against ulcerative colitis and suppresses inflammation by activating the bile acid nuclear receptor, a mechanism that was previously unrecognized, according to a new ...
Dec. 12, 2022 — A new drug acts like a master reset switch in the intestines. The compound, called FexD, has previously been found to lower cholesterol, burn fat, and ward off colorectal cancer in mice. Now, the ...
Dec. 8, 2022 — Commonly used drugs that reduce joint inflammation in patients with rheumatoid arthritis also reduce vascular inflammation and cardiovascular risk, finds a new ...
Comments
Post a Comment